Linked research, clinical, and regulatory source pathways.
Company profile
About Shenzhen Mindray Bio-Medical Electronics Co.,LTD
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a leading global medical device manufacturer that develops, manufactures, and markets a comprehensive range of medical equipment and solutions. Founded in Shenzhen, China, Mindray has established a significant presence in North America and worldwide, serving healthcare facilities across the continuum of care. The company's product portfolio spans multiple critical healthcare domains including patient monitoring systems (BeneVision N-Series), ultrasound imaging (Resona and Hepatus series), anesthesia workstations (A-Series), ventilators (SV-Series), in vitro diagnostics, and surgical tables. Mindray's patient monitoring solutions range from high-acuity continuous monitoring to telemetry and vital signs systems, featuring advanced interoperability through BeneLink and robust cybersecurity measures. Their ultrasound division offers specialized systems for general imaging, liver and gastroenterology care, women's health, and point-of-care applications, incorporating innovative technologies like Visualized Transient Elastography (ViTE) and Liver Ultrasound Attenuation (LiSA). The company's anesthesia and ventilation products serve critical care, perioperative, and out-of-hospital settings. Mindray emphasizes clinical education, technical support, and comprehensive service programs to support healthcare providers. The company maintains strategic partnerships with major healthcare organizations like Medtronic and serves diverse customer segments including health systems, ambulatory surgery centers, and private practices across multiple geographic markets.
Company description Shenzhen Mindray Bio-Medical Electronics Co.,LTD official website
Mission. We believe everyone deserves access to quality healthcare.
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- anesthesia
- cardiology
- critical care
- gastroenterology
- hepatology
- respiratory care
- women's health
Who it serves
- Ambulatory Surgery Centers
- Critical Care Facilities
- Health Systems
- Hospitals
- Private Practices
Deployment & integration
Deployment information is currently being developed.
Recorded integration context: BeneLink, DICOM, eGateway.
Geographic context
Company milestones
Platform expansion
Launched Resona A20 ultra premium ultrasound at RSNA 2025; Introduced TE Air e5M wireless handheld ultrasound (November 2025); Expanded Hepatus-Series ultrasound systems (June 2026); Entered ventilator market with SV-Series (March 2026); Expanded partnership with Medtronic to ambulatory surgery centers (January 2026); Broke ground on major warehouse expansion (June 2025)
Partnerships
Recorded partners
- Medtronic
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Advanced algorithm for correcting cold agglutination interference in red blood cell parameters with the Mindray BC-7600 hematology analyzer.Clinica chimica acta; international journal of clinical chemistry · Feb 15, 2027
Comparative evaluation of traditional and novel biomarkers for pulmonary hypertension across clinical subtypes.Clinica chimica acta; international journal of clinical chemistry · Feb 15, 2027
NT-IGFBP-4: A novel biomarker for risk prediction in acute heart failure.Clinica chimica acta; international journal of clinical chemistry · Jan 1, 2027
Granulomatous inflammation in lung and lymph node specimens: A molecularly enhanced pathology-based algorithm for etiologic differential diagnosis.Annals of diagnostic pathology · Dec 1, 2026
When morphology suggests a fusion: A pathology-centered escalation framework from histology and immunohistochemistry to RNA sequencing.Annals of diagnostic pathology · Dec 1, 2026
Preliminary study on early microvascular ingrowth into distracted callus during distraction osteogenesis-A non-invasive approach to explore the early growth patterns and possible mechanism of distraction osteogenesis in vivo.Bone · Oct 18, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
TEX20/TEX20 Pro/TEX20S/TEX20T/TEX20 Exp/TEX20 Elite Diagnostic Ultrasound System, TEX10/ TEX10 Pro/TEX10S/TEX10T/TEX10 Exp/TEX10 Elite/TE X/TE X Lite Diagnostic Ultrasound SystemK212265 · 510k · Nov 16, 2021
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
gastroenterology and hepatology care with ViTE and LiSA integration
automated measurements and AI-powered smart tools
advanced anesthesia workstation technology
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Shenzhen Mindray Bio-Medical Electronics Co.,LTD
Recent articles published on Shenzhen Mindray Bio-Medical Electronics Co.,LTD's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.